drugset
Drugs / Meningococcal ACYW135 Polysaccharide Conjugate Vaccine
last change Sep 2024 re-read 3 minutes ago

Meningococcal ACYW135 Polysaccharide Conjugate Vaccine

Vaccine

Developed for
meningococcal meningitis
Investigated by
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Air Force Military Medical University, China · Guangxi Center for Disease Control and Prevention · National Institutes for Food and Drug Control, China · Sanjiang Center for Disease Control and Prevention · Simoon Record Pharma Information Consulting Co., Ltd.

Trials 3

today NCT05252715 · Ph 3 NCT05229536 · Ph 2 NCT02878291 · Ph 1
20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT02878291 Jun → Nov 2016 meningococcal meningitis Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Unknown No outcome recorded
Phase 21 trial
Phase 2 NCT05229536 Dec 2018 → Nov 2019 meningococcal meningitis Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Completed No outcome recorded
Phase 31 trial
Phase 3 NCT05252715 Dec 2021 → Aug 2023 meningococcal meningitis Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Meningococcal ACYW135 Polysaccharide Conjugate Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT05252715 ↗
2

NCT02878291 ↗

NCT05229536 ↗
Modality Vaccine “Meningococcal ACYW135 Polysaccharide Conjugate Vaccine” NCT02878291 ↗
Route Intramuscular “Single intramuscular dose” NCT02878291 ↗